Members Directory

ABC Production+ is an Advertising & Production agency based in Milan - Italy, with offices in London (United Kingdom), New York, Phoenix (United States), Shanghai (China) and Berlin (Germany).

Briefly, the agency manages all stages of the advertising production process, having a strong focus on the high quality image retouching. The Agency sees production as a very important part of creativity that has the purpose to reach better quality and therefore a wider better work.

It has also a creative department that works for BTL and Point of sales. The Agency has collaborated with distinguished clients in the retouch of aesthetic image such as, Dolce&Gabbana, Giorgio Armani, L’Oreal, Adidas, Reebok, Bugatti, Citroen, Pirelli, Samsung, Ikea, as many others.

For more information, the agency has its own website that has been translated in 6 different languages. This international profile shows the worldwide approach ABC Production+ is aiming for, so in the future it will be known as an agency that cares in expanding the good quality of production service for advertising.

The Italian Private Equity, Venture Capital and Private Debt Association (AIFI) was founded in May 1986 in order to promote, develop and institutionally represent private equity and venture capital activity in Italy. AIFI’s objectives are to: support and facilitate the development of private equity, venture capital and private debt activity in Italy and abroad; work with government entities to improve the legal environment of the private equity, venture capital and private debt investment activity; increase awareness and understanding of the private equity, venture capital and private debt industry in Italy; coordinate the creation of qualified managerial groups both in associated companies and the connected firms; collect and present information about the industry; act as an interface and link to Italian and international financial players; create a network between research centres and venture capitalists, in order to promote successful entrepreneurial ideas; maintain ethical and professional standards in the private equity, venture capital and private debt industry. AIFI is a non-profit organisation which counted 107 full members and 125 associate members at present. Full membership is open to private equity players and venture capitalists whose main task is to take equity participations in enterprises and also to private debt players. The full members matrix is quite heterogeneous - including Italian banks and their subsidiaries, private investment companies, Italian closed-end funds, international closed-end funds as well as public players. Associate membership applies to organisations providing services to the private equity industry such as accountancy firms, law firms, banks, consultancy groups, institutions as well as Italian and foreign associations.

Independent firm of designers, planners, engineers, consultants and technical specialists offering a broad range of professional services.

The Valtidone Association is a non-profit organization created in December of 1999 with the aim of promoting and conserving the territory, history and culture of the Val Tidone, located 60 km south of Milan in the Province of Piacenza. The Valtidone has over 300 subscribers ranging from private sustaining members to agricultural and industrial firms. Association members are frequently part of the growing tourism and wine/food sectors, such as B&B’s, restaurants, hotels, agriturism, wineries, and cheese and salumi producers.

AstraZeneca is a global, innovation-driven biopharmaceutical company specialized in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference to healthcare. We have a culture of innovation, with science at the heart of everything we do. Europe is where most of our R&D efforts are conducted. AstraZeneca Italy focuses primarily on cancer (44,7%), cardiovascular/metabolic disease and diabetes (36,2%), respiratory/inflammation/autoimmunity (12,9%), infections and gastrointestinal diseases (6,2%). We are also deeply involved in projects where we believe we can make the difference: these include a significant presence on rare diseases and orphan drugs. The Company has over 750 employees in the Italian market. It has 64 clinical projects ongoing in high unmet needs areas such as oncology, respiratory, cardiovascular and diabetes. Overall there are 500 centers involved in clinical trials with over 120,000 enrolled patients. Within the AstraZeneca global trials, 2.5% of patients are from Italy, the same percentage of UK, more than Spain, and slightly less than Germany and France. In the last 3 years AstraZeneca Italy has invested almost 20 million euros in clinical research and we are firmly committed in enhancing our presence in the next coming years in light of our promising research pipeline. Current R&D expenditures amounts to EUR 6.3 on clinical trials alone.

Legal services: court proceedings and arbitration procedures with legal representation.
Legal assistance in out-of-court proceedings and in contracts in the following fields of expertise: International Commercial Law, Corporate Law, Bankruptcy Law, Employment Law, Succession, Trusts, Real Estate and International Litigation.